Kai Lehmberg, MD
University Medical Centre Hamburg Eppendorf
Hamburg, Germany

Dr. Kai Lehmberg did his undergraduate medical training in Kiel, Essen (Germany), and London (UK). He is a paediatrician at the Department of Paediatric Haematology and Oncology and the Division of Paediatric Stem Cell Transplantation and Immunology at the University Medical Centre Hamburg Eppendorf (Germany).

He has dedicated his scientific interest to clinical research in immune deficiencies and immune dysregulation with focus on haemophagocytic lymphohistiocytosis (HLH). His particular interest are stem cell transplantation for hereditary HLH and acquired forms of HLH with infectious, rheumatological, and malignant triggers.

Dr. Lehmberg heads the German national reference center for HLH in Hamburg (genetics, clinical counselling, cytology) and co-ordinates the data management of the international HLH registry, run by the Histiocyte Society and the European Society for Immune Deficiencies. He managed the European CureHLH project and coordinated the treatment studies HLH-2004 and EURO-HIT-HLH studies in Germany. He chairs the HS study group on HLH subtypes.

About the Society

The Histiocyte Society is a nonprofit organization of more than 200 physicians and scientists from around the world committed to improving the lives of patients with histiocytic disorders by conducting clinical and laboratory research into the causes and treatment of this disease.

Copyright © 2019 Histiocyte Society


Phone: +1 856 589 6606 
Fax: +1 856 589 6614
332 N Broadway
Pitman, NJ 08071 USA

Powered by Wild Apricot Membership Software